helene Moins-Teisserenc

Professor of Immunology

Université Paris Cité

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Helene Moins-Teisserenc is a Professor of Immunology at Université Paris Cité in France. Her research primarily focuses on cutaneous T-cell lymphomas, including the impacts of blood tumour clone frequency and therapeutic responses in conditions such as mycosis fungoides and Sézary syndrome. Recent publications highlight her contributions to understanding TGF-β activation and the diagnostic performance of high-throughput sequencing in T-cell lymphomas.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Anne Caignard

INSERM

FRANCE

View details

Sean Whittaker

UNITED KINGDOM

View details

Adèle de Masson

FRANCE

View details

Giovanna Motta

Istituto Europeo di Oncologia

ITALY

View details

Jean‐Marie Michot

FRANCE

View details

Martine Bagot

Prof and Head

Université Paris-Saclay

FRANCE

View details

Thi Van Anh TA

INSERM

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

helene Moins-Teisserenc

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Impact of blood tumour clone frequency on time to next treatment in mycosis fungoides

Targeting TGF-β Activation in Cutaneous T-Cell Lymphomas

Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides

Failure of second challenge with mogamulizumab in C-C chemokine receptor 4-positive cutaneous T-cell lymphoma

Severe relapses of cutaneous T‐cell lymphoma after treatment of chronic graft‐versus‐host disease with ruxolitinib

Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach

Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma

Diagnostic performance of high‐throughput sequencing of the T‐cell receptor beta gene for the diagnosis of cutaneous T‐cell lymphoma

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy

Letter to the editor with regard to the article entitled “Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping”

Ifosfamide and etoposide in advanced‐stage, relapsed or refractory primary cutaneous T‐cell lymphomas

Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR 3 DL 2 marker

Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host Disease

Collaborators (7)

Anne Caignard

Sean Whittaker

Adèle de Masson

Giovanna Motta

Jean‐Marie Michot

Martine Bagot

Thi Van Anh TA

Make your next move.